MFN2 and distal myopathy: Mitochondrial DNA (mtDNA)-mediated inflammation has recently emerged as an additional pathogenic mechanism potentially involved in CMT2A, following the identification of the novel MFN2 Q367H variant in a patient with late-onset distal myopathy (Zaman et al., 2025).